G. Dayan

发表

New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein.

D. Rigal, L. Gayet, J. Gambrelle, 2004, Nucleic acids research.

New invMED 1 element cis-activates human multidrug-related MDR 1 and MVP genes , involving the LRP 130 protein

D. Rigal, L. Gayet, J. Gambrelle, 2004 .

Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.

D. Rigal, A. Coleman, M. Michaud, 2005, Biochemistry.

Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis.

V. Oleinikov, A. Lazar, A. Coleman, 2005, The Biochemical journal.

LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer

S. Mader, I. Treilleux, T. Bachelot, 2014, International journal of cancer.

Correlation between the affinity of flavonoids binding to the cytosolic site of Leishmania tropica multidrug transporter and their efficiency to revert parasite resistance to daunomycin.

J. M. Pérez-Victoria, A. di Pietro, D. Barron, 1999, Biochemistry.

Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.

M. Lupien, J. Katzenellenbogen, S. Mader, 2007, Molecular endocrinology.

Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

A. di Pietro, D. Barron, J. Jault, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Re-epithelialization of adult skin wounds: Cellular mechanisms and therapeutic strategies.

Patricia Rousselle, Fabienne Braye, Guila Dayan, 2019, Advanced drug delivery reviews.

Gene therapy of the typical multidrug resistance phenotype of cancers: a new hope?

M. Michaud, S. Barakat, L. Baggetto, 2005, Seminars in oncology.

Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.

M. Michaud, L. Gayet, J. Gambrelle, 2005, Cancer treatment reviews.

Recombinant N-terminal Nucleotide-binding Domain from Mouse P-glycoprotein

G. Deléage, J. Cortay, J. Jault, 1996, The Journal of Biological Chemistry.

RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance

J. M. Pérez-Victoria, A. di Pietro, S. Castanys, 2003, Cellular and Molecular Life Sciences CMLS.

Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters

A. Goffeau, J. M. Pérez-Victoria, A. di Pietro, 2002, Cellular and Molecular Life Sciences CMLS.

P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.

T. Krell, A. di Pietro, J. Jault, 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Cell Surface Proteoglycans Syndecan-1 and -4 Bind Overlapping but Distinct Sites in Laminin α3 LG45 Protein Domain*

K. Beck, H. Lortat-Jacob, Sonia Carulli, 2012, The Journal of Biological Chemistry.

Perlecan expression influences the keratin 15‐positive cell population fate in the epidermis of aging skin

O. Damour, Anna Michopoulou, J. Whitelock, 2016, Aging.

Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells

S. Mader, M. Alaoui-Jamali, G. Dayan, 2002, Molecular and Cellular Endocrinology.

Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives

J. Bernaud, D. Rigal, L. Gayet, 2005, Melanoma research.

Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α

M. Lupien, J. Katzenellenbogen, S. Mader, 2006, Molecular Pharmacology.

Uveal melanoma in an 18-year-old African black man.

L. Kodjikian, L. Gayet, J. Gambrelle, 2005, Acta ophthalmologica Scandinavica.

A novel mechanism in wound healing: Laminin 332 drives MMP9/14 activity by recruiting syndecan-1 and CD44.

Anna Michopoulou, E. Lambert, P. Rousselle, 2020, Matrix biology : journal of the International Society for Matrix Biology.

The syndecan binding sequence KKLRIKSKEK in laminin α3 LG4 domain promotes epidermal repair.

Sonia Carulli, H. Chajra, P. Rousselle, 2013, European journal of dermatology : EJD.

Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site.

A. di Pietro, E. Baulieu, P. Gros, 1997, Biochemistry.

Overexpression and purification of the carboxyl-terminal nucleotide-binding domain from mouse P-glycoprotein. Strategic location of a tryptophan residue.

A. di Pietro, L. Baggetto, H. Baubichon-Cortay, 1994, The Journal of biological chemistry.

Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters

A. Goffeau, J. M. Pérez-Victoria, D. Barron, 2002, Cellular and Molecular Life Sciences CMLS.